Sollievo Pharmaceuticals

Early Stage

When Minutes Matter

Analytics

Raised to Date: Raised: $19,830

Aggregate Commitments $

Platform

StartEngine

Start Date

08/05/2022

Close Date

11/16/2022

Min. Goal

$10,000

Max. Goal

$1,070,000

Min. Investment

$400

Security Type

Equity - Common

Funding Type

RegCF

Series

Pre-Seed

Price Per Share

$2.00

Pre-Money Valuation

$20,000,000

Rolling Commitments $

Status

Active

Reporting Date

08/18/2022

Days Remaining

90

% of Min. Goal

198%

% of Max. Goal

2%

Likelihood of Max
unlikely
Avg. Daily Raise

$1,525

Momentum
cold.svg
Create a free account today to gain access to KingsCrowd analytics.
Location

San Juan Capistrano, California

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B

Margin

Medium

Capital Intensity

High

Business Type

Growth

Sollievo Pharmaceuticals, with a valuation of $20 million, is raising funds on StartEngine. The company has developed a fast-acting sedative in the form of an injectable benzodiazepine. The sedative, Proviza, causes rapid sedation in agitated and aggressive patients and protects healthcare staff from injuries and abuse. Proviza is highly water-soluble and brings about sedation in 5-10 minutes. Robert Schultz founded Sollievo Pharmaceuticals in February 2018. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,070,000. The campaign proceeds will be used for the completion of the patient clinical trial, submission of the New Drug Application, and receiving FDA approval.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-189,478

$-1,164,009

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$153

$1,157

Accounts Receivable

$0

$0

Total Assets

$153

$1,157

Short-Term Debt

$772,225

$655,821

Long-Term Debt

$1,252,890

$1,180,819

Total Liabilities

$2,025,115

$1,836,640

Financials as of: 08/05/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Sollievo Pharmaceuticals on StartEngine 2022
$
Platform: StartEngine
Security Type: Equity - Common
Valuation: $20,000,000

Follow company

Follow Sollievo Pharmaceuticals on StartEngine 2022
View on StartEngine
Bullish / Bearish
You're Bullish on Sollievo Pharmaceuticals on StartEngine 2022

Thank you for your vote on Sollievo Pharmaceuticals on StartEngine 2022

Bullish / Bearish
You're Bearish on Sollievo Pharmaceuticals on StartEngine 2022

Thank you for your vote on Sollievo Pharmaceuticals on StartEngine 2022